Showing results (451-460 of 503) with videos related to
Sort By:
Pageof 51
Nature Communications|November 6, 2024
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.Human Molecular Genetics|May 31, 2015
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among EuropeansAli Amin Al Olama, Tokhir Dadaev, Dennis J Hazelett, et al.Cancers|November 7, 2020
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.Cancer Research|November 15, 2018
A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer RiskRuth C Travis, Aurora Perez-Cornago, Paul N Appleby, et al.International Journal of Cancer|March 16, 2019
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studiesEleanor L Watts, Aurora Perez-Cornago, Paul N Appleby, et al.Nature|July 11, 2018
Prediction of acute myeloid leukaemia risk in healthy individualsSagi Abelson, Grace Collord, Stanley W K Ng, et al.International Journal of Cancer|September 5, 2025
Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analysesAmy Moore, Eleanor Kane, Lauren R Teras, et al.Frontiers in Oncology|February 18, 2020
Genetically Determined Height and Risk of Non-hodgkin LymphomaAmy Moore, Eleanor Kane, Zhaoming Wang, et al.Pageof 51